Studies have shown that GADD45B is considered a prognostic and predictive biomarker in colorectal cancer (Zhao et al., 2018) and that increased levels of GADD45B predict improved survival of prostate cancer patients (Huang et al., 2018). Here, GADD45B is linked to prostate cancer.